84.0%
resiquimodCD40 antibodyanti-CTLA4 antibodySTING agonistKPC pancreatic cancer4T1 triple-negative breast cancer
…agonist CD40 antibody, an anti-CTLA4 antibody, a STING agonist, resiquimod, and interleukin-12 (IL-12), was administered intratumorally in…